Jeffrey Busch - Mar 3, 2022 Form 4 Insider Report for Global Medical REIT Inc. (GMRE)

Role: Chairman, President and CEO, Director
Signature: /s/ Jamie Barber, as Attorney-in-Fact
Stock symbol: GMRE
Transactions as of: Mar 3, 2022
Transactions value $: $31,100
Form type: 4
Date filed: 3/4/2022, 06:11 PM
Previous filing: Mar 1, 2022
Next filing: Sep 21, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GMRE	Common Stock	Purchase	$31.1K	+2K	+4.82%	$15.55	43.5K	Mar 3, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	GMRE	LTIP Unit (Right to Buy)	Award	$0	+27.7K	+5.01%	$0.00	580K	Mar 4, 2022	Common Stock	27.7K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.
F2	As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.

Content

The Issuer's Board of Directors determined on February 24, 2022 that 50% of the LTIP Units vested and became nonforfeitable on March 4, 2022 as a result of meeting certain market-based criteria as of March 4, 2022 and 50% of the LTIP Units will vest on March 4, 2023, pursuant to the grant award agreement stipulations. The LTIP Units were awarded pursuant to an LTIP Unit vesting agreement, the form of which was filed as Exhibit 99.3 to the Issuer's Current Report on Form 8-K filed on March 7, 2019. The LTIP Units were issued pursuant to the Issuer's 2016 Equity Incentive Plan (as amended from time to time) and have no expiration date.

As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.